Nidhi’s specialisation is on Biomedical Innovation System of the country with a special focus on Emerging Technological Innovation System. Prior to joining, DST-CPR-IISc, she worked as Scientist C, at Department of Health Research- (DHR) and Indian Council of Medical Research- (ICMR), Ministry of Health & Family Welfare, during (July 2017- September 2021). Here, she was the member of COVID response team constituted at ICMR during the pandemic and also involved in the scientific evaluation and monitoring of institute’s funded research projects. She also worked as Research Associate at the Institute for Studies in Industrial Development (ISID), ICSSR, New Delhi, during (2013-2016), and as Research Assistant at the National Institute of Science Technology and Development Studies (NISTADS), CSIR, New Delhi, during (2009-2012). During her tenure at both ISID and NISTADS, she got the opportunities to assist research projects funded by World Health Organization (WHO, India), Public Health Foundation of India (PHFI), United Nations Development Programme (UNDP), National Health Systems Resource Centre (NHSRC). She has obtained her PhD degree from the Centre for studies in Science Policy, Jawaharlal Nehru University, New Delhi. All these experiences enabled her to study and learn different aspects of science policy.
Nidhi’s research interest revolves around the discipline of Science Technology and Innovation Studies to understand the social dynamics of technologies specifically the healthcare and biomedical technologies. The major focus of her research is to develop a better understanding of interface between science, technology and society in order to drive the Technological Innovations towards the needs through effective mobilization of the resources as well as optimal utilization of innovation system building activities.
Her present work “Emerging Biomedical Innovation System and its Issues and challenges” facilitates the contribution towards the development of Socially Responsible Innovation System Framework. This helps in analyzing the development and diffusion of biomedical innovations and their effective use in clinical practices for addressing the country’s specific needs.
Nidhi Singh and Kirti Tyagi (2020), “Development of ‘TrueNat’ Innovation System in India for detection of Tuberculosis and COVID-19: A System Based Perspective. Research and Information System for Developing Countries (RIS) – Discussion Paper Series- 257, 1-28.
Pramod Kumar Prajapati and Nidhi Singh (2019), “Malaria Innovation System in India: A System Based Analysis”; International Journal of Applied and Universal Research, Volume VI, Issue VI, Dec, 2019
Dinesh Abrol, AmitavaGuha, Rollins John, Nidhi Singh (2019), “India’s Domestic Pharmaceutical Firms and Their Contribution to National Innovation System- building”, Economic & Political Weekly, Vo11IV no 34, August 31, 2019, 34-43.
Singh Nidhi, & Abrol, D. (2017), ‘In-vitro diagnostics (IVDs) innovations for resource-poor settings: The Indian experience’. African Journal of Science, Technology, Innovation and Development, 9(5), 617-636.
Dinesh Abrol and Nidhi Singh (2016), “Post-TRIPS Contribution of Domestic Firms to Pharmaceutical Innovation in India: An Assessment”; International Journal of South Asian Studies: A Biannual Journal of South Asian Studies; Vol.9, No.2,2016, 155-204.
Dinesh Abrol, Sivakami Dhulap, Malini Aisola, Nidhi Singh, (2016), “Pharmaceuticals, Product Patent & TRIPS implementation”. Institute for Studies in Industrial Development (ISID) Working Paper Series –191, 1-42.
Dinesh Abrol and Nidhi Singh (2016), “PostTRIPS Contribution of Domestic Firms to Pharmaceutical Innovation in India: An Assessment”. Institute for Studies in Industrial Development (ISID) Working Paper Series –189, 1-50.
Nidhi Singh and Dinesh Abrol (2014),”Challenge of in-vitro diagnostics for resource poor settings: An Assessment” Institute for Studies in Industrial Development (ISID) Working Paper Series –166, 1-31.
Abrol Dinesh, Prajapati Pramod, and Singh Nidhi (2013), Innovation patterns, limits to learning and the pathway of neoliberal Globalisation: Evidence from Indian pharmaceutical multinationals. International Journal of Technological Learning, Innovation and Development 2, 6(1-2), 102-135.
Dinesh Abrol, Pramod Prajapati and Nidhi Singh (2011), “Globalization of the Indian Pharmaceutical Industry: Implication for Innovation”. International Journal of Institutions & Economics; Vol.3, No.2,327-365.
Dinesh Abrol, Pramod Prajapati and Nidhi Singh (2011), “Economic Reforms and Pharmaceutical Production and Innovation in India”; Rising Powers and Global Standards Network; www.risingpowers.net/node/46.
Nidhi Singh and Dinesh Abrol (2020), “In-Vitro diagnostics innovation for resource poor settings: The Indian Experiences” Swapan Kumar Patra and Mammo Muchie (Eds) Science Technology and Innovation in BRICS Countries”, Routledge.
Dinesh Abrol and Nidhi Singh (2018), “Indian Pharmaceutical Industry: Policy and Institutional Challenges of Moving from Manufacturing Generics to Drug Discovery”, in Nathan, D., Tewari, M., & Sarkar, S. (Eds.) (2018). Development with global value chains: Upgrading and innovation in Asia. Cambridge University Press.
Dinesh Abrol, Pramod Prajapati and Nidhi Singh (2014), “Recent Trends in India’s Pharmaceutical Innovation” in Sakthivel Selvaraj, Dinesh Abrol and K.M. Gopakumar (Eds) “Access to Medicines in India”, Academic Foundation.
Paper Presented in Research Conferences (National/International)
Paper Presented in Research Conferences (National/International)
“Pathways towards the development of Molecular Diagnostics Innovation System in India: Issues and Challenges” in World Conference on Access to Medical Products Achieving the SDGs 2030, 19-21 November 2019, New Delhi.
“Development and Diffusion of Molecular Diagnostics for Health care in India: Role of Industrial Based Actors” in XIV annual international conference of Knowledge Forum 2019, held at the Department of Humanities and Social Sciences, IIT Madras (11-13 October 2019).
“Development of Tuberculosis Diagnostics in India: An Innovation System Perspective” in YSI Asia Convening 2019 (Aug 12-14, 2019), Hanoi, Vietnam.
“Role of Industrial Base Actors in the Development of Molecular Diagnostics Innovation System in India: An Empirical Study” in 16th International GLOBELICS conference held at Accra 2018 (24-26 October 2018) on the theme ‘Innovation, Economic Growth and Sustainable Development: Strengthening Institutions for Greater Relevance, Effectiveness and Inclusivity’.
“Economic Liberalisation and the Development of Molecular Diagnostics Industry in India: An Innovation System Perspective” in National Seminar organized by Sikkim University, Gangtok, Sikkim, India (5-6 October 2018) on the theme ‘India after a Quarter Century of Economic Reforms – The Benefits and Costs’.
“Emerging Biomedical Technology and Healthcare System in Developing Economies” 4S SYDNEY Transnational STS: Society for Social Studies of Science annual conference Sydney International Convention Centre (29th August- 1stSeptember 2018).
“Development of Molecular Diagnostics Innovation System in India: Analysis of innovation System Functions” in The Fourth IndiaLICS International Conference (2nd – 4thNovember 2017), Organized by Centre for Studies in Science Policy (CSSP) JNU, Research and Information System for Developing Countries (RIS), National Institute for Science Technology and Development Studies (NISTADS), New Delhi on the theme ‘Innovation for Sustainable Development: Perspectives, Policies and Practices in South Asia’.
“Challenges in development of Molecular Diagnostics Innovation Systems in India” in The Third IndiaLICS International Conference (16th – 18th March 2016), Organized by Centre for Development Studies (CDS), Thiruvananthapuram, Kerala and RIS, New Delhi on the theme ‘Innovation for Sustainable Development’.
“In-vitro diagnostics innovation for resource poor settings: Indian Experience” in 13th International GLOBELICS conference held at Havana Cuba (23rd-25thSeptember 2015) on the theme ‘Innovation to reduce poverty and inequalities for inclusive and sustainable development’.
“TB and Molecular Diagnostics-Case Study in Personalized Medicine” at the King College-JNU Workshop on Biomedical Innovation and the Public, Jawaharlal Nehru University, New Delhi, March 13–14, 2014.
“Innovation, Intellectual Property Rights and Pharmaceutical Industry: Lessons from India, in National Consultation on “Improving Access; Promoting Innovation” In the context of Universal Health Coverage, WHO and Indian Institute of Technology (IIT), Madras, IIT Research Park Auditorium, Chennai 7-9 August 2014